Arrowg+ard Blue Advance PICCs and Traditional PICCs

Two — that’s the number of the most common PICC-related complications: infection and thrombosis.1,2

Central line-associated bloodstream infections (CLABSIs) are highly prevalent. Seventy percent of these infections are preventable, yet they are associated with 28,000 deaths each year and cost over $2 billion.3

Teleflex is committed to supporting vascular access specialists in their efforts to reduce vascular-related complications.

  • We offer the world's only antimicrobial and antithrombogenic PICC*
  • Using Arrowg+ard Blue Advance PICCs will help guard against CLABSI-causing pathogens in areas that are clinically out of reach4
  • This protection lasts while the line is in the patient for at least 30 days5,6

Visit our Product Catalog to see the Arrowg+ard Blue Advance PICCs and traditional PICCs, including PICCs preloaded with a stylet for use with the Arrow VPS Rhythm DLX Device and the Arrow VPS G4 Device.

Extraluminal and intraluminal protection help reduce colonization from pathogens responsible for most healthcare-associated infections6

99% colonization reduction for at least 30 days

  • Reduces thrombus accumulation on catheter surfaces5
  • Features chlorhexidine that works continuously to prevent catheter buildup of fibrin sheath, reducing the risk of intraluminal thrombotic occlusion7

In vivo intravascular studies have shown an average of 72% less intimal hyperplasia after 30 days and a reduction in phlebitis5

To help provide the tools that are specific to clinicians’ needs, Arrow PICCs are available in a range of different kits, including:

  • Max Barrier Kits
  • Interventional Radiology Kits
  • Custom PICC Kits

In a benchtop study mirroring difficult vasculature, the Arrow PICC preloaded with NaviCurve Stylet reached the SVC on the first attempt 90% of the time during catheter advancement while the BD PICC preloaded with Sherlock 3CG® Stylet reached the SVC 0% of the time during first attempt catheter advancement.10


Arrow VPS Rhythm DLX Device


  • All-in-one convenience with ultrasound, navigation, and tip confirmation
  • Vascular access ultrasound includes catheter-to-vessel ratio tool
  • Electromagnetic navigation facilitates visualization of the PICC as it advances
  • Electrocardiogram (ECG) tip location technology is indicated for use as an alternative to chest x-ray for confirmation of catheter tip placement12
  • Versatile, portable, and easy to use for bedside placement

Arrow VPS G4 Device

Intravascular ECG and Doppler technology

Easy-to-follow symbols help navigate and guide you to the lower 1/3 of the SVC-CAJ.

Simple user interface is intuitive and is designed to improve your workflow.

Confirmatory statement printout

  • Automatically indicates when a steady Blue Bullseye is achieved and captures a screenshot with a confirmatory statement — “Tip placed at lower 1/3 of the SVC or at CAJ.”

Kit Features

All-inclusive ergonomic Arrow Max Barrier PICC Kits are designed to provide everything you need for bedside insertion, including pre-packaged components for less prep time

  • One-piece drape
  • Redesigned Arrow Trimmer with visualization window
  • Ultrasound probe cover with gel
  • Prefilled Saline Syringes packaged inside the kit
  • Available with 3M Tegaderm CHG I.V. Securement Dressing or BioPatch® Protective Disk
  • Extra ChloraPrep® Skin Prep applicators in each kit

Kit Features

  • Arrow Traditional and Arrowg+ard Blue Advance PICC kits are designed specifically for your IR needs
  • Simplified kit with single-tray design
  • No need to open full kit to complete procedure

Additional Resources

Arrow PICC Ordering Information
VPS Rhythm DLX Device Product Overview Video
VPS Rhythm DLX Brochure
PICC Preloaded with NaviCurve Stylet Digital Demo
Catheter-to-Vessel Ratio (CVR) Video
Teleflex Academy
PICC Brochure

References:

  1. Grau D, Clarivet B, Lotthé A, Bommart S, Parer S. Complications with peripherally inserted central catheters (PICCs) used in hospitalized patients and outpatients: a prospective cohort study. Antimicrob Resist Infect Control. 2017;6:18. doi:10.1186/s13756-016-0161-0

  2. Moreau N. Preventing PICC complications: whose line is it? Patient Safety Network. December 1, 2012. Accessed January 9, 2023. https://psnet.ahrq.gov/web-mm/preventing-picc-complications-whose-line-it

  3. Estimating the additional hospital inpatient cost and mortality associated with selected hospital-acquired conditions. Agency for Healthcare Research and Quality. November 2017. Accessed November 9, 2022. https://www.ahrq.gov/hai/pfp/haccost2017-results.html

  4. ADHX-001612: Design History File Index for VPS RhythmTM DLX System.

  5. As compared to uncoated PICCs, intravascular ovine model inoculated with Staph aureus: AVAR-000427. No correlation between in vitro/in vivo testing methods and clinical outcomes have currently been ascertained.

  6. In vitro data on file 2010: AVER-004371, AVER-004483 and AVAR-000427. No correlation between in vitro/in vivo testing methods and clinical outcomes has currently been ascertained.

  7. As compared to uncoated PICCs, in vitro model measuring flush pressure post exposure to bovine blood: AVER-006376. No correlation between in vitro/in vivo testing methods and clinical outcomes has currently been ascertained.

  8. Gorski LA, Hadaway L, Hagle ME, et al. Infusion Therapy Standards of Practice, 8th Edition. J Infus Nurs. 2021;44(1S Suppl 1):S1-S224.

  9. DLX-200-OPM-US: VPS Rhythm DLX Operator's Manual.

  10. D041679: IMH Benchtop Stylet Advancement in a Simulated Use Anatomical Model of NaviCurve>. Product Stylet/PICC Assemblies.


*As of September 2023


Rx only

Contraindication:

Clinical assessment of the patient must be completed to ensure no contraindications exist.

The Arrowg+ard Blue Advance PICC is contraindicated in the following areas:

  • Patients with known hypersensitivity to chlorhexidine
  • In presence of device-related infections
  • In presence of previous or current thrombosis in the intended vessel or along the catheterized vessel pathway.

No correlation between in vitro/in vivo testing methods and clinical outcomes have currently been ascertained.

For complete indications, contraindications, warnings, precautions, and adverse reactions, please reference each referenced product's full package insert.

ChloraPrep and Sherlock 3CG are registered trademarks of Becton, Dickinson and Company. 3M and Tegaderm are registered trademarks of 3M. BioPatch is a registered trademark of Johnson & Johnson.

Teleflex, the Teleflex logo, Arrow, Arrowg+ard Blue Advance, NaviCurve, TaperFree, VPS G4, and VPS Rhythm are trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. All other trademarks are trademarks of their respective owners. MC-000752 Rev 2